194 related articles for article (PubMed ID: 31251475)
1. Polycystin-1 affects cancer cell behaviour and interacts with mTOR and Jak signalling pathways in cancer cell lines.
Papavassiliou KA; Zoi I; Gargalionis AN; Koutsilieris M
J Cell Mol Med; 2019 Sep; 23(9):6215-6227. PubMed ID: 31251475
[TBL] [Abstract][Full Text] [Related]
2. Polycystin-1 and polycystin-2 are involved in the acquisition of aggressive phenotypes in colorectal cancer.
Gargalionis AN; Korkolopoulou P; Farmaki E; Piperi C; Dalagiorgou G; Adamopoulos C; Levidou G; Saetta A; Fragkou P; Tsioli P; Kiaris H; Zizi-Serbetzoglou A; Karavokyros I; Papavassiliou KA; Tsavaris N; Patsouris E; Basdra EK; Papavassiliou AG
Int J Cancer; 2015 Apr; 136(7):1515-27. PubMed ID: 25123959
[TBL] [Abstract][Full Text] [Related]
3. Divergent function of polycystin 1 and polycystin 2 in cell size regulation.
Viau A; Kotsis F; Boehlke C; Braeg S; Klein M; Nitschke R; Walz G; Kuehn EW
Biochem Biophys Res Commun; 2020 Jan; 521(2):290-295. PubMed ID: 31668373
[TBL] [Abstract][Full Text] [Related]
4. Polycystin-1 Enhances Stemmness Potential of Umbilical Cord Blood-Derived Mesenchymal Stem Cells.
Jung SH; You JE; Choi SW; Kang KS; Cho JY; Lyu J; Kim PH
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34064452
[TBL] [Abstract][Full Text] [Related]
5. Polycystin-1 induces activation of the PI3K/AKT/mTOR pathway and promotes angiogenesis in renal cell carcinoma.
Gargalionis AN; Sarlani E; Stofas A; Malakou LS; Adamopoulos C; Bamias A; Boutati E; Constantinides CA; Stravodimos KG; Piperi C; Papavassiliou AG; Korkolopoulou P
Cancer Lett; 2020 Oct; 489():135-143. PubMed ID: 32561414
[TBL] [Abstract][Full Text] [Related]
6. Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells.
de Stephanis L; Bonon A; Varani K; Lanza G; Gafà R; Pinton P; Pema M; Somlo S; Boletta A; Aguiari G
Clin Exp Nephrol; 2017 Apr; 21(2):203-211. PubMed ID: 27278932
[TBL] [Abstract][Full Text] [Related]
7. Polycystin-1 downregulation induces ERK-dependent mTOR pathway activation in a cellular model of psoriasis.
Gargalionis AN; Malakou LS; Adamopoulos C; Piperi C; Theohari I; Nokhbehsaim M; Deschner J; Kokkalis G; Korkolopoulou P; Papadavid E; Papavassiliou AG; Basdra EK
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3468-3476. PubMed ID: 30077613
[TBL] [Abstract][Full Text] [Related]
8. Role of PKR in the Inhibition of Proliferation and Translation by Polycystin-1.
Tang Y; Shi G; Yang J; Zheng W; Tang J; Chen XZ; Yang J; Wang Z
Biomed Res Int; 2019; 2019():5320747. PubMed ID: 31341901
[TBL] [Abstract][Full Text] [Related]
9. Polycystin-1 Inhibits Cell Proliferation through Phosphatase PP2A/B56
Tang Y; Yang J; Zheng W; Tang J; Chen XZ; Yang J; Wang Z
Biomed Res Int; 2019; 2019():2582401. PubMed ID: 31641668
[TBL] [Abstract][Full Text] [Related]
10. Polycystin-1 negatively regulates Polycystin-2 expression via the aggresome/autophagosome pathway.
Cebotaru V; Cebotaru L; Kim H; Chiaravalli M; Boletta A; Qian F; Guggino WB
J Biol Chem; 2014 Mar; 289(10):6404-6414. PubMed ID: 24459142
[TBL] [Abstract][Full Text] [Related]
11. A role for polycystin-1 and polycystin-2 in neural progenitor cell differentiation.
Winokurow N; Schumacher S
Cell Mol Life Sci; 2019 Jul; 76(14):2851-2869. PubMed ID: 30895336
[TBL] [Abstract][Full Text] [Related]
12. Polycystin-1: function as a mechanosensor.
Dalagiorgou G; Basdra EK; Papavassiliou AG
Int J Biochem Cell Biol; 2010 Oct; 42(10):1610-3. PubMed ID: 20601082
[TBL] [Abstract][Full Text] [Related]
13. Polycystin-1 interacts with inositol 1,4,5-trisphosphate receptor to modulate intracellular Ca2+ signaling with implications for polycystic kidney disease.
Li Y; Santoso NG; Yu S; Woodward OM; Qian F; Guggino WB
J Biol Chem; 2009 Dec; 284(52):36431-36441. PubMed ID: 19854836
[TBL] [Abstract][Full Text] [Related]
14. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease.
Shillingford JM; Murcia NS; Larson CH; Low SH; Hedgepeth R; Brown N; Flask CA; Novick AC; Goldfarb DA; Kramer-Zucker A; Walz G; Piontek KB; Germino GG; Weimbs T
Proc Natl Acad Sci U S A; 2006 Apr; 103(14):5466-71. PubMed ID: 16567633
[TBL] [Abstract][Full Text] [Related]
15. Polycystin and calcium signaling in cell death and survival.
Lemos FO; Ehrlich BE
Cell Calcium; 2018 Jan; 69():37-45. PubMed ID: 28601384
[TBL] [Abstract][Full Text] [Related]
16. Polycystin-1 maturation requires polycystin-2 in a dose-dependent manner.
Gainullin VG; Hopp K; Ward CJ; Hommerding CJ; Harris PC
J Clin Invest; 2015 Feb; 125(2):607-20. PubMed ID: 25574838
[TBL] [Abstract][Full Text] [Related]
17. Regulation of mTOR by polycystin-1: is polycystic kidney disease a case of futile repair?
Weimbs T
Cell Cycle; 2006 Nov; 5(21):2425-9. PubMed ID: 17102641
[TBL] [Abstract][Full Text] [Related]
18. Altered trafficking and stability of polycystins underlie polycystic kidney disease.
Cai Y; Fedeles SV; Dong K; Anyatonwu G; Onoe T; Mitobe M; Gao JD; Okuhara D; Tian X; Gallagher AR; Tang Z; Xie X; Lalioti MD; Lee AH; Ehrlich BE; Somlo S
J Clin Invest; 2014 Dec; 124(12):5129-44. PubMed ID: 25365220
[TBL] [Abstract][Full Text] [Related]
19. Genetic Mechanisms of ADPKD.
Kim DY; Park JH
Adv Exp Med Biol; 2016; 933():13-22. PubMed ID: 27730431
[TBL] [Abstract][Full Text] [Related]
20. Progressive development of polycystic kidney disease in the mouse model expressing Pkd1 extracellular domain.
Kurbegovic A; Trudel M
Hum Mol Genet; 2013 Jun; 22(12):2361-75. PubMed ID: 23439951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
